March 21, 2025
However, Novo Nordisk, Ozempics manufacturer, released results from two clinical trials in November 2025 that showed that taking an oral GLP-1 didnt slow disease progression among people with Alzheimers compared to those who took a placebo
Contact your GP, diabetes specialist nurse, or NHS 111 if: Headaches are persistent, worsening, or significantly impacting daily activities despite simple management measures You experience frequent hypoglycaemic episodes (blood glucose below 4 mmol/L) [31] [32] You have signs of dehydration such as reduced urine output, excessive thirst, or dizziness when standing Side effects are affecting medication adherence or quality of life You develop new or unusual symptoms that concern you Headaches follow a different pattern from any pre-existing headache disorder Healthcare professionals can assess whether headaches are likely related to GLP-1 therapy or require investigation for alternative causes
CBO expects the costs (which would be in Part D) to continue to outweigh the savings (which would mostly be in Part A and some in Part B) into a second decade through 2044, though the gap between the two will decrease
Statistics and reproducibility All data were processed, analyzed, and visualized using GraphPad Prism 9 Software (version 9.5.1) (GraphPad Software, Inc.)
